Please use this identifier to cite or link to this item: https://scholarbank.nus.edu.sg/handle/10635/25401
DC FieldValue
dc.titleOVEREXPRESSION OF TYRO3 AND ITS IMPLICATION ON HEPATOCELLULAR CARCINOMA (HCC) PROGRESSION
dc.contributor.authorDUAN YAN
dc.date.accessioned2011-08-05T18:00:11Z
dc.date.available2011-08-05T18:00:11Z
dc.date.issued2011-04-26
dc.identifier.citationDUAN YAN (2011-04-26). OVEREXPRESSION OF TYRO3 AND ITS IMPLICATION ON HEPATOCELLULAR CARCINOMA (HCC) PROGRESSION. ScholarBank@NUS Repository.
dc.identifier.urihttp://scholarbank.nus.edu.sg/handle/10635/25401
dc.description.abstractThe lack of effective treatment against hepatocellular carcinoma (HCC), the fifth most common malignancy and the third leading cause of cancer deaths worldwide calls for direct efforts to better understand the disease and identify new drug targets. In the search for novel multi-kinase inhibitors to treat this disease, our group found a very potent compound which acts on a relatively uncharacterized receptor tyrosine kinase, Tyro3. To explore the potential role of tyrosine kinase Tyro3 in HCC, we examined the expression of Tyro3 in HCC tumors and correlated it with clinical outcomes. Using cDNAs derived from 56 HCC patients and quantitative RT-PCR (qRT-PCR) analysis of Tyro3, we found frequent and significant overexpression which also corresponded to elevation of clinico-pathological markers for HCC such as hepatitis B virus (HBV) infection, a-fetoprotein (AFP), aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels. To determine the cause-and-effect relationship between Tyro3 expression and these HCC phenotypes, we performed in vitro investigation using siRNA silencing of Tyro3 in a high expressing HCC cell line, Hep3B and found it to suppress cell proliferation. From these efforts, we have gathered important basis for further work to characterize Tyro3 as a potential and novel drug target in HCC. Of equal importance, we have successfully developed useful and relevant in vitro models that will support subsequent effort to understand the exact mechanism behind its effect.
dc.language.isoen
dc.subjectTyro3, tyrosine kinase, hepatocellular carcinoma, alpha-fetoprotein, cell proliferation
dc.typeThesis
dc.contributor.departmentPHARMACY
dc.contributor.supervisorHO HAN KIAT
dc.contributor.supervisorChua Boon Tin
dc.description.degreeMaster's
dc.description.degreeconferredMASTER OF SCIENCE
dc.identifier.isiutNOT_IN_WOS
Appears in Collections:Master's Theses (Open)

Show simple item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
DuanY.PDF430.78 kBAdobe PDF

OPEN

NoneView/Download

Page view(s)

348
checked on May 21, 2019

Download(s)

65
checked on May 21, 2019

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.